Hostname: page-component-586b7cd67f-rdxmf Total loading time: 0 Render date: 2024-11-25T17:02:11.403Z Has data issue: false hasContentIssue false
  • English
  • Français

Sarcopenia: a clinical review

Published online by Cambridge University Press:  17 October 2013

AJ Cruz-Jentoft
AJ Cruz-Jentoft*
Affiliation:
Servicio de Geriatría, Hospital Universitario Ramón y Cajal, Madrid, Spain
*
Address for correspondence: Dr Alfonso Cruz-Jentoft, Servicio de Geriatría, Hospital Universitario Ramón y Cajal, Ctra. Colmenar km 9.1, 28034 Madrid, Spain. Email: [email protected]
Get access Rights & Permissions [Opens in a new window]

Summary

Although sarcopenia has been used to define muscle mass loss in older subjects, muscle mass is not directly linked to muscle function. Recent definitions consider sarcopenia as a syndrome characterized by progressive and generalized loss of skeletal muscle mass and strength with a risk of adverse outcomes, such as physical disability, poor quality of life, and death. It is closely linked with physical frailty, and also with other muscle wasting disorders, including cachexia and malnutrition. This review focuses on the incorporation of sarcopenia into clinical practice, reviews case finding and diagnosis of sarcopenia, proposes a syndromic approach for the diagnostic work-up of sarcopenic patients, and looks at intervention trials with physical exercise and nutrition, as drugs to treat this condition are not expected to be available in the near future.

Keywords

sarcopeniafrail elderlymuscleskeletal
Type
Review Article
Information
Reviews in Clinical Gerontology , Volume 23 , Issue 4 , November 2013 , pp. 267 - 274
Copyright
Copyright © Cambridge University Press 2013 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1Rosenberg, IH. Sarcopenia: origins and clinical relevance. J Nutr 1997; 127 (suppl 5): 990–91S.CrossRefGoogle ScholarPubMed
2Vandewoude, MF, Cederholm, T, Cruz-Jentoft, AJ. Relevant outcomes in intervention trials for sarcopenia. J Am Geriatr Soc 2011; 59: 1566–67.CrossRefGoogle ScholarPubMed
3Cruz-Jentoft, AJ, Morley, JE. Sarcopenia. Chichester, West Sussex; Hoboken, NJ: Wiley-Blackwell; 2012.CrossRefGoogle ScholarPubMed
4Janssen, I. The epidemiology of sarcopenia. Clin Geriatr Med 2011; 27: 355–63.CrossRefGoogle ScholarPubMed
5Manini, TM, Clark, BC. Dynapenia and aging: an update. J Gerontol A Biol Sci Med Sci 2012; 67: 28–40.CrossRefGoogle ScholarPubMed
6Mijnarends, DM, Meijers, JMM, Halfens, RJGet al.Validity and reliability of tools to measure muscle mass, strength, and physical performance in community-dwelling older people: a systematic review. J Am Med Dir Assoc 2013; 14: 170–78.CrossRefGoogle ScholarPubMed
7Bijlsma, AY, Meskers, CG, Ling, CHet al.Defining sarcopenia: the impact of different diagnostic criteria on the prevalence of sarcopenia in a large middle aged cohort. Age (Dordr) 2013; 35: 871–81.CrossRefGoogle Scholar
8Papanicolaou, DA, Ather, SN, Zhu, Het al.A phase IIA randomized, placebo-controlled clinical trial to study the efficacy and safety of the selective androgen receptor modulator (SARM), MK-0773 in female participants with sarcopenia. J Nutr Health Aging 2013; 17: 533–43.CrossRefGoogle Scholar
9Muscaritoli, M, Anker, SD, Argiles, Jet al.Consensus definition of sarcopenia, cachexia and pre-cachexia: Joint document elaborated by Special Interest Groups (SIG) ‘cachexia-anorexia in chronic wasting diseases’ and ‘nutrition in geriatrics’. Clin Nutr 2010; 29: 154–59.CrossRefGoogle ScholarPubMed
10Fielding, RA, Vellas, B, Evans, WJet al.Sarcopenia: an undiagnosed condition in older adults. Current consensus definition: prevalence, etiology, and consequences. International working group on sarcopenia. J Am Med Dir Assoc 2011; 12: 249–56.CrossRefGoogle ScholarPubMed
11Morley, JE, Abbatecola, AM, Argiles, JMet al.Sarcopenia with limited mobility: an international consensus. J Am Med Dir Assoc 2011; 12: 403–9.CrossRefGoogle ScholarPubMed
12Cruz-Jentoft, AJ, Baeyens, JP, Bauer, JMet al.Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People. Age Ageing 2010; 39: 412–23.CrossRefGoogle ScholarPubMed
13Patel, HP, Syddall, HE, Jameson, Ket al.Prevalence of sarcopenia in community-dwelling older people in the UK using the European Working Group on Sarcopenia in Older People (EWGSOP) definition: findings from the Hertfordshire Cohort Study (HCS). Age Ageing 2013; 42: 378–84.CrossRefGoogle Scholar
14Landi, F, Liperoti, R, Fusco, Det al.Prevalence and risk factors of sarcopenia among nursing home older residents. J Gerontol A Biol Sci Med Sci 2012; 67: 48–55.CrossRefGoogle ScholarPubMed
15Landi, F, Liperoti, R, Fusco, Det al.Sarcopenia and mortality among older nursing home residents. J Am Med Dir Assoc 2012; 13: 121–26.CrossRefGoogle ScholarPubMed
16Landi, F, Liperoti, R, Russo, Aet al.Sarcopenia as a risk factor for falls in elderly individuals: Results from the ilSIRENTE study. Clin Nutr 2012; 31: 652–58.CrossRefGoogle ScholarPubMed
17Arango-Lopera, VE, Arroyo, P, Gutiérrez-Robledo, LM, Pérez-Zepeda, MU, Cesari, M. Mortality as an adverse outcome of sarcopenia. J Nutr Health Aging 2013; 17: 259–62.CrossRefGoogle ScholarPubMed
18Lee, W-J, Liu, L-K, Peng, L-N, Lin, M-H, Chen, L-K. Comparisons of sarcopenia defined by IWGS and EWGSOP criteria among older people: results from the I-Lan Longitudinal Aging Study. J Am Med Dir Assoc 2013; 14: 528. e1–7.CrossRefGoogle ScholarPubMed
19Fried, LP, Tangen, CM, Walston, Jet al.Frailty in older adults: evidence for a phenotype. J Gerontol Biol Sci Med Sci 2001; 56: M146–56.CrossRefGoogle ScholarPubMed
20Rodriguez-Mañas, L, Feart, C, Mann, Get al.Searching for an operational definition of frailty: a Delphi Method Based Consensus Statement. The Frailty Operative Definition-Consensus Conference Project. J Gerontol A Biol Sci Med Sci 2013; 68: 62–67.CrossRefGoogle ScholarPubMed
21Rockwood, K, Bergman, H. FRAILTY: A Report from the 3rd Joint Workshop of IAGG/WHO/SFGG, Athens, January 2012. Can Geriatr J 2012; 15: 31–36.CrossRefGoogle ScholarPubMed
22Deane, AJB, Jaafar, AF. An update on frailty diagnosis and management. Rev Clin Gerontol 2013; Epub ahead of print.CrossRefGoogle Scholar
23Bouillon, K, Kivimaki, M, Hamer, Met al.Measures of frailty in population-based studies: an overview. BMC Geriatr 2013; 13: 64–75.CrossRefGoogle ScholarPubMed
24Michel, JP, Cruz-Jentoft, AJ. Sarcopenia: a useful paradigm for physical frailty. Eur Geriatr Med 2013; 4: 102–5.Google Scholar
25Jeejeebhoy, KN. Malnutrition, fatigue, frailty, vulnerability, sarcopenia and cachexia: overlap of clinical features. Curr Opin Clin Nutr Metab Care 2012; 15: 213–19.CrossRefGoogle ScholarPubMed
26Cooper, C, Dere, W, Evans, Wet al.Frailty and sarcopenia: definitions and outcome parameters. Osteoporosis Int 2012; 23: 1839–48.CrossRefGoogle ScholarPubMed
27Rizzoli, R, Reginster, J-Y, Arnal, J-Fet al.Quality of life in sarcopenia and frailty. Calcif Tissue Int 2013; 93: 101–20.CrossRefGoogle ScholarPubMed
28Drey, M, Sieber, CC, Bauer, JM, Uter, W, Dahinden, P, Fariello, RGet al.C-terminal Agrin Fragment as a potential marker for sarcopenia caused by degeneration of the neuromuscular junction. Exp Gerontol 2013; 48: 76–80.CrossRefGoogle ScholarPubMed
29Cruz-Jentoft, AJ, Landi, F, Topinkova, E, Michel, JP. Understanding sarcopenia as a geriatric syndrome. Curr Opin Clin Nutr Metab Care 2010; 13: 1–7.CrossRefGoogle ScholarPubMed
30Olde Rikkert, MG, Rigaud, AS, Van Hoeyweghen, RJ, de Graaf, J. Geriatric syndromes: medical misnomer or progress in geriatrics? Neth J Med 2003; 61: 83–87.Google ScholarPubMed
31Inouye, SK, Studenski, S, Tinetti, ME, Kuchel, GA. Geriatric syndromes: clinical, research, and policy implications of a core geriatric concept. J Am Geriatr Soc 2007; 55: 780–91.CrossRefGoogle ScholarPubMed
32Sjöblom, S, Suuronen, J, Rikkonen, T, Honkanen, R, Kröger, H, Sirola, J. Relationship between postmenopausal osteoporosis and the components of clinical sarcopenia. Maturitas 2013; 75: 175–80.CrossRefGoogle ScholarPubMed
33Cederholm, T, Cruz-Jentoft, AJ, Maggi, S. Sarcopenia and fragility fractures. Eur J Phys Rehabil Med 2013; 49: 111–17.Google ScholarPubMed
34Kaji, H. Linkage between muscle and bone: common catabolic signals resulting in osteoporosis and sarcopenia. Curr Opin Clin Nutr Metab Care 2013; 16: 272–77.CrossRefGoogle ScholarPubMed
35Thomas, DR. Loss of skeletal muscle mass in aging: examining the relationship of starvation, sarcopenia and cachexia. Clin Nutr 2007; 26: 389–99.CrossRefGoogle ScholarPubMed
36Evans, WJ, Morley, JE, Argiles, Jet al.Cachexia: a new definition. Clin Nutr 2008; 27: 793–99.CrossRefGoogle ScholarPubMed
37Dodds, R, Denison, HJ, Ntani, Get al.Birth weight and muscle strength: a systematic review and meta-analysis. J Nutr Health Aging 2012; 16: 609–15.CrossRefGoogle ScholarPubMed
38Candow, DG, Forbes, SC, Little, JP, Cornish, SM, Pinkoski, C, Chilibeck, PD. Effect of nutritional interventions and resistance exercise on aging muscle mass and strength. Biogerontology 2012; 13: 345–58.CrossRefGoogle ScholarPubMed
39Caspersen, CJ, Powell, KE, Christenson, GM. Physical activity, exercise, and physical fitness: definitions and distinctions for health-related research. Public Health Reports Wash 1985; 100: 126–31.Google ScholarPubMed
40Chastin, SF, Ferriolli, E, Stephens, NA, Fearon, KC, Greig, C. Relationship between sedentary behaviour, physical activity, muscle quality and body composition in healthy older adults. Age Ageing 2012; 41: 111–14.CrossRefGoogle ScholarPubMed
41Ryu, M, Jo, J, Lee, Y, Chung, Y-S, Kim, K-M, Baek, W-C. Association of physical activity with sarcopenia and sarcopenic obesity in community-dwelling older adults: the Fourth Korea National Health and Nutrition Examination Survey. Age Ageing 2013 (Epub ahead of print: 11 June).CrossRefGoogle Scholar
42Kim, S-H, Kim, T-H, Hwang, H-J. The relationship of physical activity (PA) and walking with sarcopenia in Korean males aged 60 years and older using the Fourth Korean National Health and Nutrition Examination Survey (KNHANES IV-2, 3), 2008–2009. Arch Gerontol Geriatr 2013; 56: 472–77.CrossRefGoogle ScholarPubMed
43Hamer, M, Stamatakis, E. Screen-based sedentary behavior, physical activity, and muscle strength in the English longitudinal study of ageing. PloS One 2013; 8: e66222.CrossRefGoogle ScholarPubMed
44Timmerman, KL, Dhanani, S, Glynn, ELet al.A moderate acute increase in physical activity enhances nutritive flow and the muscle protein anabolic response to mixed nutrient intake in older adults. Am J Clin Nutr 2012; 95: 1403–12.CrossRefGoogle ScholarPubMed
45Scanlon, TC, Fragala, MS, Stout, JRet al. Muscle architecture and strength: adaptations to short term resistance training. Muscle Nerve 2013 (Epub ahead of print: 28 July).Google Scholar
46Fry, CS, Drummond, MJ, Glynn, ELet al.Skeletal muscle autophagy and protein breakdown following resistance exercise are similar in younger and older adults. J Gerontol A Biol Sci Med Sci 2013; 68: 599–607.CrossRefGoogle ScholarPubMed
47Forbes, SC, Little, JP, Candow, DG. Exercise and nutritional interventions for improving aging muscle health. Endocrine 2012; 42: 29–38.CrossRefGoogle ScholarPubMed
48Peterson, MD, Sen, A, Gordon, PM. Influence of resistance exercise on lean body mass in aging adults: a meta-analysis. Med Sci Sports Exerc 2011; 43: 249–58.CrossRefGoogle ScholarPubMed
49Serra-Rexach, JA, Bustamante-Ara, N, Hierro, VMet al.Short-term, light- to moderate-intensity exercise training improves leg muscle strength in the oldest old: a randomized controlled trial. J Am Geriatr Soc 2011; 59: 594–602.CrossRefGoogle ScholarPubMed
50Tieland, M, Dirks, ML, van der Zwaluw, Net al.Protein supplementation increases muscle mass gain during prolonged resistance-type exercise training in frail elderly people: a randomized, double-blind, placebo-controlled trial. J Am Med Dir Assoc 2012; 13: 713–19.CrossRefGoogle ScholarPubMed
51Vandewoude, MFJ, Alish, CJ, Sauer, AC, Hegazi, RA. Malnutrition-sarcopenia syndrome: is this the future of nutrition screening and assessment for older adults? J Aging Res 2012; article ID 651570.CrossRefGoogle Scholar
52Bauer, J, Biolo, G, Cederholm, Tet al. Evidence-based Recommendations for Optimal Dietary Protein Intake in Older People: A Position Paper From the PROT-AGE Study Group. J Am Med Dir Assoc 2013 (Epub ahead of print: 15 July).CrossRefGoogle Scholar
53Aleman-Mateo, H, Macias, L, Esparza-Romero, J, Astiazaran-Garcia, H, Blancas, AL. Physiological effects beyond the significant gain in muscle mass in sarcopenic elderly men: evidence from a randomized clinical trial using a protein-rich food. Clin Interv Aging 2012; 7: 225–34.CrossRefGoogle ScholarPubMed
54Leenders, M, van Loon, LJC. Leucine as a pharmaconutrient to prevent and treat sarcopenia and type 2 diabetes. Nutr Rev 2011; 69: 675–89.CrossRefGoogle ScholarPubMed
55Deutz, NE, Pereira, SL, Hays, NPet al. Effect of β-hydroxy-β-methylbutyrate (HMB) on lean body mass during 10 days of bed rest in older adults. Clin Nutr 2013 (Epub ahead of print: 4 March).CrossRefGoogle Scholar
56Candow, DG. Sarcopenia: current theories and the potential beneficial effect of creatine application strategies. Biogerontology 2011; 12: 273–81.CrossRefGoogle ScholarPubMed
57Burd, NA, Yang, Y, Moore, DR, Tang, JE, Tarnopolsky, MA, Phillips, SM. Greater stimulation of myofibrillar protein synthesis with ingestion of whey protein isolate v. micellar casein at rest and after resistance exercise in elderly men. Br J Nutr 2012; 108: 958–62.CrossRefGoogle ScholarPubMed
58Björkman, MP, Pilvi, TK, Kekkonen, RA, Korpela, R, Tilvis, RS. Similar effects of leucine-rich and regular dairy products on muscle mass and functions of older polymyalgia rheumatica patients: a randomized crossover trial. J Nutr Health Aging 2011; 15: 462–67.CrossRefGoogle ScholarPubMed
59Brotto, M, Abreu, EL. Sarcopenia: pharmacology of today and tomorrow. J Pharmacol Exp Ther 2012; 343: 540–46.CrossRefGoogle ScholarPubMed
60Rolland, Y, Onder, G, Morley, JE, Gillette-Guyonet, S, Abellan van Kan, G, Vellas, B. Current and future pharmacologic treatment of sarcopenia. Clin Geriatr Med 2011; 27: 423–47.CrossRefGoogle ScholarPubMed
61Maggio, M, Lauretani, F, Ceda, GP. Sex hormones and sarcopenia in older persons. Curr Opin Clin Nutr Metab Care 2013; 16: 3–13.Google ScholarPubMed
62Gumucio, JP, Mendias, CL. Atrogin-1, MuRF-1 and sarcopenia. Endocrine 2013; 43: 12–21.CrossRefGoogle ScholarPubMed
63MacDonald, EM, Cohn, RD. TGFβ signaling: its role in fibrosis formation and myopathies. Curr Opin Rheumatol 2012; 24: 628–34.CrossRefGoogle ScholarPubMed
64Marzetti, E, Calvani, R, Bernabei, R, Leeuwenburgh, C. Apoptosis in skeletal myocytes: a potential target for interventions against sarcopenia and physical frailty – a mini-review. Gerontology 2012; 58: 99–106.CrossRefGoogle ScholarPubMed
65Elliott, B, Renshaw, D, Getting, S, Mackenzie, R.The central role of myostatin in skeletal muscle and whole body homeostasis. Acta Physiol Oxf 2012; 205: 324–40.CrossRefGoogle ScholarPubMed
66Clark, DJ, Fielding, RA. Neuromuscular contributions to age-related weakness. J Gerontol A Biol Sci Med Sci 2012; 67: 41–47.CrossRefGoogle ScholarPubMed
67Brass, EP, Sietsema, KE. Considerations in the development of drugs to treat sarcopenia. J Am Geriatr Soc 2011; 59: 530–35.CrossRefGoogle ScholarPubMed